In its first-quarter 2025 investor letter, Parnassus Core Equity Fund highlighted stocks such as The Cigna Group (NYSE:CI).

Financial Performance. Cigna has demonstrated resilience in its financial performance, with analysts projecting solid earnings growth. For the fiscal year 2025, earnings per share (EPS) estimates ...

Cigna Group's performance and all-time high raise questions about selling its stock, but I still prefer to hold despite high valuation. Read more on CI stock here.

Cigna stock (NYSE: CI), a health insurance and pharmacy services management company, has seen a 9% rise in a month, significantly outperforming the broader S&P500 index, which fell 5%. CI stock is ...

Cigna Corporation (NYSE: CI) has reached an impressive milestone, with its stock price soaring to an all-time high of $370.82.This peak reflects a significant growth trajectory for the health ...

In the latest market close, Cigna (CI) reached $292.07, with a +0.54% movement compared to the previous day. The stock outpaced the S&P 500's daily gain of 0.45%. The upcoming earnings release of ...

Analyst Justin Lake of Wolfe Research reiterated a Buy rating on Cigna (CI – Research Report), with a price target of $323.00. Justin Lake gave his rating of Cigna’s stock based on a number of ...

Cigna (NYSE:CI) stock rose ~4% premarket Aug. 4 after Q2 results beat estimates and the company raised its FY22 outlook Adjusted EPS grew +18.7% Y/Y to $6.22, while total revenues increased +5.45% ...

Cigna stock soars to all-time high, reaches $365.83 ...

Cigna stock (NYSE: CI), a health insurance and pharmacy services management company, has seen a 9% rise in a month, significantly outperforming the broader S&P500 index, which fell 5%.